Three paths.
One remarkable plant.

A reading sequence through different kinds of evidence. Each step identifies whether the connection is documented or an editorial change of question.

1. Ed Rosenthal ↗

   Start with the record and its sources.

2. Cannabis Grower’s Handbook: The Complete Guide to Marijuana and Hemp Cultivation ↗

   Documented connection

   Ed Rosenthal is a named author of “Cannabis Grower’s Handbook: The Complete Guide to Marijuana and Hemp Cultivation”.

   Named authorship in the original publication or verified edition. Only profiles admitted to this collection appear as nodes; the work retains its broader author list.
3. Cannabis sativa L. ↗

   Documented connection

   “Cannabis Grower’s Handbook: The Complete Guide to Marijuana and Hemp Cultivation” treats cannabis horticulture; Cannabis sativa L. identifies its botanical subject.

   The credited 2021 handbook discusses cannabis horticulture; its bibliographic scope is connected to the taxon. It is not the source for each anatomical finding. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
4. Glandular trichome ↗

   Documented connection

   Glandular trichome opens an anatomical description of Cannabis sativa L.

   A documented structure within the taxon; schematic scale and variation remain explicit. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
5. From plant anatomy to cannabinoid biosynthesis ↗

   Documented connection

   Experiments on glandular trichomes provide the connection to this biosynthetic pathway.

   Expression, activity and reporter evidence supported the authors’ proposed THCA-synthase localization. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
6. Δ9-Tetrahydrocannabinolic acid A ↗

   Documented connection

   The experimentally studied pathway forms Δ9-Tetrahydrocannabinolic acid A; this is a chemical relationship.

   THCA is the enzyme reaction product. This edge does not mean direct enzymatic synthesis of neutral THC. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
7. Δ9-Tetrahydrocannabinol ↗

   Documented connection

   Δ9-Tetrahydrocannabinolic acid A is the acid precursor of Δ9-Tetrahydrocannabinol. They remain separate chemical identities.

   The acid precursor and neutral molecule are different chemical entities. The connection is explanatory, with no conversion procedure. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
8. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish ↗

   Documented connection

   “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish” reports work characterizing Δ9-Tetrahydrocannabinol. The finding and its limits are stated below.

   Chemical isolation and structure; not a claim of first traditional use.
9. Raphael Mechoulam ↗

   Documented connection

   Raphael Mechoulam is a named author of “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish”.

   Named authorship in the original publication or verified edition. Only profiles admitted to this collection appear as nodes; the work retains its broader author list.
10. CB1 ↗

    Editorial change of question

    From Raphael Mechoulam, open CB1 to ask a different question. No direct evidential relationship is asserted by this reading order.

    Chemical identification, receptor research and a clinical treatment claim are different findings. Mechoulam is not credited alone for team discoveries.

Follow chemical identification, then a separately documented receptor experiment and endogenous signalling. A later paper is not an automatic validation of an earlier claim.

1. Raphael Mechoulam ↗

   Start with the record and its sources.

2. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish ↗

   Documented connection

   Raphael Mechoulam is a named author of “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish”.

   Named authorship in the original publication or verified edition. Only profiles admitted to this collection appear as nodes; the work retains its broader author list.
3. Δ9-Tetrahydrocannabinol ↗

   Documented connection

   “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish” reports work characterizing Δ9-Tetrahydrocannabinol. The finding and its limits are stated below.

   Chemical isolation and structure; not a claim of first traditional use.
4. CB1 ↗

   Editorial change of question

   From Δ9-Tetrahydrocannabinol, open CB1 to ask a different question. No direct evidential relationship is asserted by this reading order.

   Chemical identification, receptor research and a clinical treatment claim are different findings. Mechoulam is not credited alone for team discoveries.
5. Structure of a cannabinoid receptor and functional expression of the cloned cDNA ↗

   Documented connection

   “Structure of a cannabinoid receptor and functional expression of the cloned cDNA” reports work characterizing CB1. The finding and its limits are stated below.

   Molecular cloning and functional expression, not an atomic structure.
6. Isolation and structure of a brain constituent that binds to the cannabinoid receptor ↗

   Editorial change of question

   From Structure of a cannabinoid receptor and functional expression of the cloned cDNA, open Isolation and structure of a brain constituent that binds to the cannabinoid receptor to ask a different question. No direct evidential relationship is asserted by this reading order.

   Chemical identification, receptor research and a clinical treatment claim are different findings. Mechoulam is not credited alone for team discoveries.
7. CB1 ↗

   Editorial change of question

   From Isolation and structure of a brain constituent that binds to the cannabinoid receptor, open CB1 to ask a different question. No direct evidential relationship is asserted by this reading order.

   Chemical identification, receptor research and a clinical treatment claim are different findings. Mechoulam is not credited alone for team discoveries.
8. Cannabis sativa L. ↗

   Editorial change of question

   From CB1, open Cannabis sativa L. to ask a different question. No direct evidential relationship is asserted by this reading order.

   Authorship and botanical description do not establish medicinal efficacy, permission to cultivate, or endorsement of Mount Herbs.
9. Ed Rosenthal ↗

   Editorial change of question

   From Cannabis sativa L., open Ed Rosenthal to ask a different question. No direct evidential relationship is asserted by this reading order.

   Authorship and botanical description do not establish medicinal efficacy, permission to cultivate, or endorsement of Mount Herbs.

The official identity leads to the plant. Textual context and modern chemistry remain separate branches, not evidence that one authorizes the other.

1. Vijayā — the official index entry ↗

   Start with the record and its sources.

2. Cannabis sativa L. ↗

   Documented connection

   The official Vijayā index identifies its botanical material as Cannabis sativa L.

   The official index names Cannabis sativa Linn. for Vijayā. This joins botanical identity only, not all parts or preparations. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
3. Palmately compound leaf ↗

   Documented connection

   Palmately compound leaf opens an anatomical description of Cannabis sativa L.

   A documented structure within the taxon; schematic scale and variation remain explicit. This relation establishes neither clinical efficacy, endorsement of Mount Herbs, nor medicinal authorization.
4. Pharmacopoeia and formulary ↗

   Editorial change of question

   From Palmately compound leaf, open Pharmacopoeia and formulary to ask a different question. No direct evidential relationship is asserted by this reading order.

   Pharmacopoeial inclusion does not authorize cultivation, manufacture, marketing or prescribing, and does not validate every claim about cannabis compounds.
5. An Ayurvedic vocabulary for materials and bodies ↗

   Editorial change of question

   From Pharmacopoeia and formulary, open An Ayurvedic vocabulary for materials and bodies to ask a different question. No direct evidential relationship is asserted by this reading order.

   Pharmacopoeial inclusion does not authorize cultivation, manufacture, marketing or prescribing, and does not validate every claim about cannabis compounds.
6. Vijayā ↗

   Editorial change of question

   From An Ayurvedic vocabulary for materials and bodies, open Vijayā to ask a different question. No direct evidential relationship is asserted by this reading order.

   Pharmacopoeial inclusion does not authorize cultivation, manufacture, marketing or prescribing, and does not validate every claim about cannabis compounds.
7. Δ9-Tetrahydrocannabinol ↗

   Editorial change of question

   From Vijayā, open Δ9-Tetrahydrocannabinol to ask a different question. No direct evidential relationship is asserted by this reading order.

   Chemical identification, receptor research and a clinical treatment claim are different findings. Mechoulam is not credited alone for team discoveries.
8. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish ↗

   Documented connection

   “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish” reports work characterizing Δ9-Tetrahydrocannabinol. The finding and its limits are stated below.

   Chemical isolation and structure; not a claim of first traditional use.